Malaysian Association of Pharmaceutical Suppliers (MAPS)
President's Message - December 2017
All of a sudden the last month of the year is upon us. How time flies. Since my last message several things have happened.
As a follow through of the June joint meeting of the industry, MAPS, PhAMA and MOPI, we managed to have a fruitful meeting on August 24th with the Secretary-General of the Ministry of Health, Datuk Seri Dr Chen Chaw Min together with senior members of his team. We managed to discuss and hear on various issues including the SL1M program, proposal on mandatory declaration of medicine prices, corporatisation of NPRA, Healthcare Transformation, Patient Assisted Program (PAP) and the direction of hologram/track and trace system.
This was followed up by a further discussion on September 7th, with the Bahagian Perkhidmatan Farmasi to work out the mechanics of the price declaration. Members are reminded to register with the Mypharma-C portal to report on the prices.
Also following through on the meeting with the Secretary-General, a closed door meeting was held on October 13th on the track and trace system, which would be the first in a series of such meetings. Ultimately the aim of this system is to provide an end-to-end track and trace system to enhance the safety features of medicine supply.
On the competition front, there have been a series of meetings held by the MyCC Pharmaceutical Steering Committee, and the appointed consultants to review the Pharmaceutical market. This has resulted in the publication of a draft report of the Pharmaceutical review available on the MyCC website. Two public consultations were called to gather feedback from the public, in Kuala Lumpur (November 22) and Penang (November 24). Another avenue for feedback is via the MyCC website. As a reminder, if you have any feedback please provide tit through the link on the website by December 7th 9.00 am.
As you can see, MAPS is very actively engaged to represent the interests which are aligned to yours. Shortly, we will be sending out notices for membership renewal for 2018. A notice on the 2018 Annual General Meeting will be sent out early 2018. You need to be a fully paid up member, in order to exercise your rights.
Another exciting event is the Workshop on API, BE & LAB exclusive event with MAPS on 18 January 2018. This event will feature speakers from the NPRA. The secretariat has informed that within just 2 days of opening registration 1/3rd of available seats have already been registered. Do hurry to register, as this is a highly valuable session.
Finally, I take this time to wish an early Christmas greeting to you and a happy new year.
LIM TENG CHYUAN
Also on this page: links for Membership Application Form, Code of Conduct, Membership list, Member login
If you would like to read previous messages by the President, please visit our archive (click this)
Foreword by the PresidentI am delighted to welcome you to the MAPS website and I hope you will find the information provided here to be useful for the pharmaceutical industry in Malaysia.
I welcome participation from members to be active in subcommittees that have been formed in order to make MAPS an association where everyone can openly suggest, exchange ideas, share issues and values of common interests. Membership of MAPS is open to any company involved in pharmaceutical trade (importer and / or distributor) in Malaysia.
I look forward to warmly welcome you into MAPS.
Why we exist
The first gathering of “like-minded” interest Group for the formation of the “Malaysian Association of Pharmaceutical Suppliers (MAPS)” was on 17th March 2011 held in the premise of Medispec, Taman Mayang, Petaling Jaya.
MAPS was formally registered with the Registrar of Society on the 17th November 2011.
It was formed to fill in the "missing piece" in the trade representation in the Pharmaceutical Industry.
MAPS is having representations and engaging with the relevant Government bodies like the Bahagian Farmasi, BPFK, PEMANDU, MyCC, etc, on issues relating to the pharmaceutical trade.
MAPS is in the forefront of issues facing the Industry which means that the voices and interests of MAPS will be heard and considered. Thus, MAPS will have the opportunity to continuously collaborate and consult on the policies and regulations affecting the industry.
Board of Directors
Lim Teng Chyuan
Choe Tong Seng
Heng Thin Fook
Lee Choon Hian
Yeo Ann Chin
Choe Tong Seng
If your company qualifies to be a member, and in concurrence with our goals, please apply for membership. Click here for the membership form.
Technical Working Groups/ External committees
MAPS practises a high ethical code. Members are required to abide by this conduct to ensure that the industry maintains a high level of integrity. Click here for MAPS' code of conduct.
Members of MAPS are Malaysian Companies which import pharmaceuticals into the country. They represent principals from Europe, North America, Asia, Oceania etc. The principals may be R&D or generic manufacturers from these regions.
|Ethics||Lim Teng Chyuan||Somedico|
|Regulatory||Yeo Ann Chin||Pharmaforte|
|Social & Sports||Mathew John||Jetpharma|
|Trade Practices||Heng Thin Fook||Medispec|
As an association, MAPS is committed to build the industry together with the respective government authorities and the industry stakeholders. The country has to have an industry that is conducive to attract investments with an ecosystem of "fairness, healthy, vibrancy, dynamic, skill and knowledgeable" and "an equitable, accessible and affordable healthcare for the rakyat in the country".
Click on this to view the membership list.
Click here to enter the members-only pages.